Phosphorylation of eukaryotic elongation factor 2 can be regulated by phosphoinositide 3-kinase in the early stages of myoblast differentiation

Molecules and Cells

Volumn 21, Issue 2, 2006, Pages 294-301

  Woo, Joo Hong ^a   Kim, Hye Sun ^a  

^a Ajou University   (South Korea)

Author keywords

Cell cycle; Eukaryotic elongation factor 2 (eEF2); LY 294002; Myoblast differentiation; Phosphoinositide 3 kinase (PI3 kinase)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D1; ELONGATION FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL STIMULATION; CELL SYNCHRONIZATION; CONTROLLED STUDY; CULTURE MEDIUM; DEVELOPMENTAL STAGE; ENZYME ACTIVATION; EUKARYOTE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CULTURE MEDIA; ENZYME ACTIVATION; MUSCLE, SKELETAL; MYOBLASTS; PEPTIDE ELONGATION FACTOR 2; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RATS;

ANIMALIA; EUKARYOTA;

EID: 33646594065     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M. G., et al. (1996) 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrest human breast cancer cells. Oncogene 12, 2315-2324.
2. 2+/ calmodulin-dependent phosphorylation of the 100-kDa protein and membrane fusion of chick embryonic myoblasts. Dev. Biol. 165, 178-184.
3. Browne, G. J., Finn, S. G., and Proud, C. G. (2004) Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor-2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279, 12220-12231.
4. Canicio, J., Gallardo, E., Illa, I., Testar, X., Palacin, M., et al. (1998) p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. Endocrinology 139, 5042-5049.
5. Casagrande, F., Bacqueville, D., Pillaire, M. J., Malecaze, F., Manenti, S., et al. (1998) G1 phase arrest by the phosphatidy-linositol 3-kinase inhibitor LY294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells. FEBS Lett. 422, 385-390.
6. Conejo, R., Valverde, A. M., Benito, M., and Lorenzo, M. (2001) Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities. J. Cell Physiol. 86, 82-94.
7. Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., and Florini, J. R. (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662.
8. Cortright, D. N., Azevedo, J. L. Jr., Hickey, M. S., Tapscott, E. B., and Dohm, G. L. (1997) Vanadate stimulation of 2-deoxyglucose transport is not mediated by PI3-kinase in human skeletal muscle. Biochim. Biophys. Acta 1358, 300-306.
9. Cuenda, A. and Cohen, P. (1999) Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274, 4341-4346.
10. De Angelis, L., Borghi, S., Melchionna, R., Berghella, L., Baccarani-Contri, M., et al. (1998) Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Natl. Acad. Sci. USA 95, 12358-12363.
11. Fingar, D. C. and Blenis, J. (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23, 3151-3171.
12. Florini, J. R., Ewton, D. Z., and Coolican, S. A. (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17, 481-517.
13. Foulstone, E. J., Meadows, K. A., Holly, J. M., and Stewart, C. E. (2001) Insulin-like growth factor (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J. Cell Physiol. 189, 207-215.
14. Gao, N., Zhang, Z., Jiang, B. H., and Shi, X. (2003) Role of PI3K/AKT/ mTOR signaling in the cell cycle progression of human prostate cancer. Biochem. Biophys. Res. Commun. 310, 1124-1132.
15. Giorgino, F., Pedrini, M. T., Matera, L., and Smith, R. J. (1997) Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J. Biol. Chem. 272, 7455-7463.
16. Guo, K., Wang, J., Andres, V., Smith, R. C., and Walsh, K. (1995) MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocytes terminal differentiation. Mol. Cell. Biol. 15, 3823-3829.
17. Gutzkow, K. B., Lahne, H. U., Naderi, S., Torgersen, K. M., Skalhegg, B., et al. (2003) Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation. Cell Signal. 15, 871-881.
18. Halevy, O., Novitch, B. G., Douglas, B. S., Skapek, S. X., Rhee, J., et al. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1024.
19. Hay, N. and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945.
20. Jeon, Y. J., Kim, H. S., Kim, H. S., Kang, M. S., Chung, C. H., et al. (1994) The 100-kDa protein, whose phosphorylation precedes the fusion of chick embryonic myoblasts, is the eukaryotic longation factor-2. Biochem. Biophys. Res. Commun. 198, 132-137.
21. Jiang, B. H., Aoki, M., Zheng, J. Z., Li, J., and Vogt, P. K. (1999) Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96, 2077-2081.
22. Kaliman, P., Vinals, F., Testar, X., Palacin, M., and Zorzano, A. (1996) Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271, 19146-19151.
23. Kaliman, P., Canicio, J., Shepherd, P. R., Beeton, C. A., Testar, X., et al. (1998) Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol. Endocrinol. 12, 66-77.
24. Kiess, M., Gill, R. M., and Hamel, P. A. (1995) Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6, 1287-1298.
25. 2+/calmodulin-dependent phosphorylation of the 100-kDa protein in chick embryonic muscle cells in culture. Dev. Biol. 150, 223-230.
26. Kim, H. S., Lee, I. H., Jeon, Y. J., Chung, C. H., and Ha, D. B. (1993) Sphingosine blocks both membrane ftision and calmodulin-dependent phosphorylation of the 100-kDa protein of chick embryonic myoblasts. Exp. Cell Res. 205, 408-411.
27. Kimura, K., Hattori, S., Kabuyama, Y., Shizawa, Y., Takayanagi, J., et al. (1994) Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 269, 18961-18967.
28. Kriebel, A., Morrice, N., and Cohen, P. (2001) A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20, 4360-4369.
29. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
30. Lanahan, A., Williams, J. B., Sanders, L. K., and Nathans, D. (1992) Growth factor-induced delayed early response genes. Mol. Cell. Biol. 12, 3919-3929.
31. Lassar, A. B., Skapek, S. X., and Novitch, B. (1994) Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6, 788-794.
32. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/ p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616.
33. Matsushime, H., Roussel, M. F., Ashmun, R. A., and Sherr, C. J. (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65, 701-713.
34. Miyatake, S., Nakano, H., Park, S. Y., Yamazaki, T., Takase, K., et al. (1995) Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas. J. Exp. Med. 182, 401-408.
35. Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., et al. (1998) Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273, 29864-29872.
36. Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., et al. (1993) Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13, 3577-3587.
37. Nadal-Ginard, B. (1978) Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15, 855-864.
38. Nairn, A. C., Bhagat, B., and Palfrey, H. C. (1985) Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues. Proc. Natl. Acad. Sci. USA 82, 7939-7943.
39. Nilsson, A. and Nygard, O. (1995) Phosphorylation of eukaryotic elongation factor 2 in differentiating and proliferating HL-60 cells. Biochim. Biophys. Acta 1268, 263-268.
40. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568-3573.
41. Olson, E. N. and Klein, W. H. (1994) bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8, 1-8.
42. 2+ transients. J. Biol. Chem. 262, 9785-9792.
43. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., et al. (1995) p53-independent expression of p21Cipl in muscle and other terminally differentiating cells. Science 267, 1024-1026.
44. Patel, J., McLeod, L. E., Vries, R. G., Flynn, A., Wang, X., et al. (2002) Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur J. Biochem. 269, 3076-3085.
45. Pinset, C., Garcia, A., Rousse, S., Dubois, C., and Montarras, D. (1997) Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2. C. R. Acad. Sci. III 320, 367-374.
46. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., et al. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7, 1559-1571.
47. Rameh, L. E. and Cantley, L. C. (1999) The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274, 8347-8350.
48. Ryazanov, A. G. (2002) Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett. 514, 26-29.
49. Ryazanov, A. G. and Davydova, E. K. (1989) Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation. FEBS Lett. 251, 187-190.
50. Ryazanov, A. G. and Spirin, A. S. (1993) Phosphorylation of elongation factor 2; a mechanism to shut off protein synthesis for reprogramming gene expression; in Translational Regulation of Gene Expression 2, Ilan, J. (ed.), pp. 433-455, Plenum Press, New York.
51. Ryazanov, A. G., Shestakova, E. A., and Natapov, P. G. (1988) Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 334, 170-173.
52. Sarker, K. P. and Lee, K. Y. (2004) L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Oncogene 23, 6064-6070.
53. Shin, Y. J., Woo, J. H., Chung, C. H., and Kim, H. S. (2000) Retinoic acid and its geometrical isomers block both growth and fusion of L6 myoblasts by modulating the expression of protein kinase A. Mol. Cells 10, 162-168.
54. Shu, L., Zhang, X., and Houghton, P. J. (2002) Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J. Biol. Chem. 277, 16726-16732.
55. Thomas, J. E., Venugopalan, M., Galvin, R., Wang, Y., Bokoch, G. M., et al. (1997) Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. J. Cell. Biochem. 64, 182-195.
56. Tuazon, P. T., Merrick, W. C., and Traugh, J. A. (1989) Comparative analysis of phosphorylation of translational initiation and elongation factors by seven protein kinases. J. Biol. Chem. 264, 2773-2777.
57. Valius, M. and Kazlauskas, A. (1993) Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73, 321-334.
58. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
59. Wang, X., Li W., Williams, M., Terada, N., Alessi, D. R., and Proud, C. G. (2001) Regulation of elongation factor 2 kinase by p90 (RSK1) and p70 S6 kinase. EMBO J. 20, 4370-4379.
60. Watts, C. K., Sweeney, K. J., Warlters, A., Musgrove, E. A., and Sutherland, R. L. (1994) Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 31, 95-105.
61. Woo, J. H., Kim, J. H., Mook-Jung, I., and Kim, H. S. (2006) Lipid products of phosphoinositide 3-kinase abrogate genistein-induced fusion inhibition in myoblasts. Eur. J. Pharmacol. 529, 84-94.
62. Yao, R. and Cooper, G. M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
63. Zhang, P., Wong, C., Liu, D., Finegold, M., Harper, J. W., et al,,. (1999) p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev. 13, 213-224.
64. Zieve, G. W., Turnbull, D., Mullins, J. M., and McIntosh, J. R. (1980) Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell Res. 2, 397-405.